ID   RS3_HUMAN               Reviewed;         243 AA.
AC   P23396; B2R7N5; J3KN86; Q498B5; Q8NI95;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 2.
DT   28-JAN-2026, entry version 255.
DE   RecName: Full=Small ribosomal subunit protein uS3 {ECO:0000303|PubMed:24524803};
DE   AltName: Full=40S ribosomal protein S3 {ECO:0000303|PubMed:2129557};
DE            EC=4.2.99.18 {ECO:0000269|PubMed:7775413};
GN   Name=RPS3 {ECO:0000303|PubMed:11875025}; ORFNames=OK/SW-cl.26;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2129557; DOI=10.1093/nar/18.22.6689;
RA   Zhang X.T., Tan Y.M., Tan Y.H.;
RT   "Isolation of a cDNA encoding human 40S ribosomal protein s3.";
RL   Nucleic Acids Res. 18:6689-6689(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1712897; DOI=10.1128/mcb.11.8.3842-3849.1991;
RA   Pogue-Geile K., Geiser J.R., Shu M., Miller C., Wool I.G., Meisler A.I.,
RA   Pipas J.M.;
RT   "Ribosomal protein genes are overexpressed in colorectal cancer: isolation
RT   of a cDNA clone encoding the human S3 ribosomal protein.";
RL   Mol. Cell. Biol. 11:3842-3849(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11875025; DOI=10.1101/gr.214202;
RA   Yoshihama M., Uechi T., Asakawa S., Kawasaki K., Kato S., Higa S.,
RA   Maeda N., Minoshima S., Tanaka T., Shimizu N., Kenmochi N.;
RT   "The human ribosomal protein genes: sequencing and comparative analysis of
RT   73 genes.";
RL   Genome Res. 12:379-390(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal cortex, Liver, Lymph, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 1-94 (ISOFORM 1).
RX   PubMed=8319909; DOI=10.1101/gad.7.7a.1176;
RA   Tycowski K.T., Shu M.D., Steitz J.A.;
RT   "A small nucleolar RNA is processed from an intron of the human gene
RT   encoding ribosomal protein S3.";
RL   Genes Dev. 7:1176-1190(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-8; 10-64; 68-116; 118-141; 152-173; 186-197 AND
RP   202-243, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, and Colon adenocarcinoma;
RA   Bienvenut W.V., Murray L., Brunton V.G., Frame M.C., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-243 (ISOFORM 1).
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-reactive
RT   CTL generated from TIL of colon cancer patients.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   PROTEIN SEQUENCE OF 10-40; 46-54; 76-90; 95-106; 109-116; 118-132; 152-173;
RP   179-185; 188-197 AND 202-243, PHOSPHORYLATION AT THR-221, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [13]
RP   PROTEIN SEQUENCE OF 188-197.
RC   TISSUE=Placenta;
RX   PubMed=8706699; DOI=10.1111/j.1432-1033.1996.0144u.x;
RA   Vladimirov S.N., Ivanov A.V., Karpova G.G., Musolyamov A.K., Egorov T.A.,
RA   Thiede B., Wittmann-Liebold B., Otto A.;
RT   "Characterization of the human small-ribosomal-subunit proteins by N-
RT   terminal and internal sequencing, and mass spectrometry.";
RL   Eur. J. Biochem. 239:144-149(1996).
RN   [14]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=7775413; DOI=10.1074/jbc.270.23.13620;
RA   Kim J., Chubatsu L.S., Admon A., Stahl J., Fellous R., Linn S.;
RT   "Implication of mammalian ribosomal protein S3 in the processing of DNA
RT   damage.";
RL   J. Biol. Chem. 270:13620-13629(1995).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH APEX1 AND OGG1.
RX   PubMed=15518571; DOI=10.1021/bi049234b;
RA   Hegde V., Wang M., Deutsch W.A.;
RT   "Human ribosomal protein S3 interacts with DNA base excision repair
RT   proteins hAPE/Ref-1 and hOGG1.";
RL   Biochemistry 43:14211-14217(2004).
RN   [17]
RP   FUNCTION.
RX   PubMed=14706345; DOI=10.1016/j.dnarep.2003.10.004;
RA   Hegde V., Wang M., Deutsch W.A.;
RT   "Characterization of human ribosomal protein S3 binding to 7,8-dihydro-8-
RT   oxoguanine and abasic sites by surface plasmon resonance.";
RL   DNA Repair 3:121-126(2004).
RN   [18]
RP   FUNCTION.
RX   PubMed=14988002; DOI=10.1016/s0014-5793(04)00074-2;
RA   Jang C.Y., Lee J.Y., Kim J.;
RT   "RpS3, a DNA repair endonuclease and ribosomal protein, is involved in
RT   apoptosis.";
RL   FEBS Lett. 560:81-85(2004).
RN   [19]
RP   FUNCTION, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15707971; DOI=10.1016/j.bbrc.2005.01.045;
RA   Kim S.H., Lee J.Y., Kim J.;
RT   "Characterization of a wide range base-damage-endonuclease activity of
RT   mammalian rpS3.";
RL   Biochem. Biophys. Res. Commun. 328:962-967(2005).
RN   [20]
RP   PHOSPHORYLATION AT THR-42, AND MUTAGENESIS OF THR-42 AND THR-221.
RX   PubMed=15950189; DOI=10.1016/j.bbrc.2005.05.079;
RA   Kim H.D., Lee J.Y., Kim J.;
RT   "Erk phosphorylates threonine 42 residue of ribosomal protein S3.";
RL   Biochem. Biophys. Res. Commun. 333:110-115(2005).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   MUTAGENESIS OF LYS-132.
RX   PubMed=16737853; DOI=10.1016/j.dnarep.2006.04.001;
RA   Hegde V., Wang M., Mian I.S., Spyres L., Deutsch W.A.;
RT   "The high binding affinity of human ribosomal protein S3 to 7,8-dihydro-8-
RT   oxoguanine is abrogated by a single amino acid change.";
RL   DNA Repair 5:810-815(2006).
RN   [23]
RP   INTERACTION WITH HSP90, SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=16314389; DOI=10.1091/mbc.e05-08-0713;
RA   Kim T.S., Jang C.Y., Kim H.D., Lee J.Y., Ahn B.Y., Kim J.;
RT   "Interaction of Hsp90 with ribosomal proteins protects from ubiquitination
RT   and proteasome-dependent degradation.";
RL   Mol. Biol. Cell 17:824-833(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [26]
RP   FUNCTION, INTERACTION WITH RELA, IDENTIFICATION IN THE NF-KAPPA-B P65-P50
RP   COMPLEX, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18045535; DOI=10.1016/j.cell.2007.10.009;
RA   Wan F., Anderson D.E., Barnitz R.A., Snow A., Bidere N., Zheng L.,
RA   Hegde V., Lam L.T., Staudt L.M., Levens D., Deutsch W.A., Lenardo M.J.;
RT   "Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that
RT   mediates selective gene regulation.";
RL   Cell 131:927-939(2007).
RN   [27]
RP   FUNCTION.
RX   PubMed=17049931; DOI=10.1016/j.dnarep.2006.09.004;
RA   Hegde V., Yadavilli S., Deutsch W.A.;
RT   "Knockdown of ribosomal protein S3 protects human cells from genotoxic
RT   stress.";
RL   DNA Repair 6:94-99(2007).
RN   [28]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION, AND MUTAGENESIS OF THR-42.
RX   PubMed=17560175; DOI=10.1016/j.dnarep.2007.04.009;
RA   Yadavilli S., Hegde V., Deutsch W.A.;
RT   "Translocation of human ribosomal protein S3 to sites of DNA damage is
RT   dependant on ERK-mediated phosphorylation following genotoxic stress.";
RL   DNA Repair 6:1453-1462(2007).
RN   [29]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.m600346-mcp200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [30]
RP   FUNCTION.
RX   PubMed=18610840;
RA   Balyeva K.E., Malygin A.A., Karpova G.G., Nevinskii G.A., Zharkov D.O.;
RT   "Interactions of human ribosomal protein S3 with undamaged and damaged
RT   DNA.";
RL   Mol. Biol. (Mosk.) 42:314-322(2008).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-242, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [32]
RP   FUNCTION, AND INTERACTION WITH UNG.
RX   PubMed=18973764; DOI=10.1016/j.mrfmmm.2008.09.013;
RA   Ko S.I., Park J.H., Park M.J., Kim J., Kang L.W., Han Y.S.;
RT   "Human ribosomal protein S3 (hRpS3) interacts with uracil-DNA glycosylase
RT   (hUNG) and stimulates its glycosylase activity.";
RL   Mutat. Res. 648:54-64(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [34]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [35]
RP   INTERACTION WITH PRMT1, SUBCELLULAR LOCATION, AND METHYLATION AT ARG-64;
RP   ARG-65 AND ARG-67.
RX   PubMed=19460357; DOI=10.1016/j.bbrc.2009.05.055;
RA   Shin H.S., Jang C.Y., Kim H.D., Kim T.S., Kim S., Kim J.;
RT   "Arginine methylation of ribosomal protein S3 affects ribosome assembly.";
RL   Biochem. Biophys. Res. Commun. 385:273-278(2009).
RN   [36]
RP   INTERACTION WITH PRKCD, PHOSPHORYLATION AT SER-6 AND THR-221, AND
RP   MUTAGENESIS OF SER-6; SER-35; THR-42; THR-70; SER-139; SER-149; THR-195 AND
RP   THR-221.
RX   PubMed=19059439; DOI=10.1016/j.bbamcr.2008.10.017;
RA   Kim T.S., Kim H.D., Kim J.;
RT   "PKCdelta-dependent functional switch of rpS3 between translation and DNA
RT   repair.";
RL   Biochim. Biophys. Acta 1793:395-405(2009).
RN   [37]
RP   FUNCTION, INTERACTION WITH MDM2 AND TP53, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19656744; DOI=10.1016/j.dnarep.2009.07.003;
RA   Yadavilli S., Mayo L.D., Higgins M., Lain S., Hegde V., Deutsch W.A.;
RT   "Ribosomal protein S3: A multi-functional protein that interacts with both
RT   p53 and MDM2 through its KH domain.";
RL   DNA Repair 8:1215-1224(2009).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [39]
RP   INTERACTION WITH E.COLI NLEH1 AND NLEH2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=20041225; DOI=10.1371/journal.ppat.1000708;
RA   Gao X., Wan F., Mateo K., Callegari E., Wang D., Deng W., Puente J., Li F.,
RA   Chaussee M.S., Finlay B.B., Lenardo M.J., Hardwidge P.R.;
RT   "Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB
RT   function.";
RL   PLoS Pathog. 5:E1000708-E1000708(2009).
RN   [40]
RP   IDENTIFICATION IN A HCV IRES-MEDIATED TRANSLATION COMPLEX.
RX   PubMed=19541769; DOI=10.1261/rna.1578409;
RA   Weinlich S., Huettelmaier S., Schierhorn A., Behrens S.-E.,
RA   Ostareck-Lederer A., Ostareck D.H.;
RT   "IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3'UTR.";
RL   RNA 15:1528-1542(2009).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [42]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-62, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [43]
RP   INTERACTION WITH E2F1 AND PKB, PHOSPHORYLATION AT THR-70, AND MUTAGENESIS
RP   OF THR-70.
RX   PubMed=20605787; DOI=10.1074/jbc.m110.131367;
RA   Lee S.B., Kwon I.S., Park J., Lee K.H., Ahn Y., Lee C., Kim J., Choi S.Y.,
RA   Cho S.W., Ahn J.Y.;
RT   "Ribosomal protein S3, a new substrate of Akt, serves as a signal mediator
RT   between neuronal apoptosis and DNA repair.";
RL   J. Biol. Chem. 285:29457-29468(2010).
RN   [44]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20217897; DOI=10.1002/jcb.22537;
RA   Kim H.D., Kim T.S., Joo Y.J., Shin H.S., Kim S.H., Jang C.Y., Lee C.E.,
RA   Kim J.;
RT   "RpS3 translation is repressed by interaction with its own mRNA.";
RL   J. Cell. Biochem. 110:294-303(2010).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [47]
RP   INTERACTION WITH SUMO1 AND UBC9, SUMOYLATION AT LYS-18; LYS-214 AND
RP   LYS-230, AND MUTAGENESIS OF LYS-18; LYS-214 AND LYS-230.
RX   PubMed=21968017; DOI=10.1016/j.bbrc.2011.09.099;
RA   Jang C.Y., Shin H.S., Kim H.D., Kim J.W., Choi S.Y., Kim J.;
RT   "Ribosomal protein S3 is stabilized by sumoylation.";
RL   Biochem. Biophys. Res. Commun. 414:523-527(2011).
RN   [48]
RP   INTERACTION WITH CDK1, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-221,
RP   AND MUTAGENESIS OF SER-6; THR-42 AND THR-221.
RX   PubMed=21871177; DOI=10.5483/bmbrep.2011.44.8.529;
RA   Yoon I.S., Chung J.H., Hahm S.H., Park M.J., Lee Y.R., Ko S.I., Kang L.W.,
RA   Kim T.S., Kim J., Han Y.S.;
RT   "Ribosomal protein S3 is phosphorylated by Cdk1/cdc2 during G2/M phase.";
RL   BMB Rep. 44:529-534(2011).
RN   [49]
RP   INTERACTION WITH IKKB AND E.COLI NLEH1, PHOSPHORYLATION AT SER-209, AND
RP   MUTAGENESIS OF SER-209.
RX   PubMed=21399639; DOI=10.1038/ni.2007;
RA   Wan F., Weaver A., Gao X., Bern M., Hardwidge P.R., Lenardo M.J.;
RT   "IKKbeta phosphorylation regulates RPS3 nuclear translocation and NF-kappaB
RT   function during infection with Escherichia coli strain O157:H7.";
RL   Nat. Immunol. 12:335-343(2011).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [51]
RP   FUNCTION, AND INTERACTION WITH TRADD.
RX   PubMed=22510408; DOI=10.1016/j.bbrc.2012.04.020;
RA   Jang C.Y., Kim H.D., Kim J.;
RT   "Ribosomal protein S3 interacts with TRADD to induce apoptosis through
RT   caspase dependent JNK activation.";
RL   Biochem. Biophys. Res. Commun. 421:474-478(2012).
RN   [52]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23131551; DOI=10.1016/j.bbrc.2012.10.093;
RA   Jang C.Y., Kim H.D., Zhang X., Chang J.S., Kim J.;
RT   "Ribosomal protein S3 localizes on the mitotic spindle and functions as a
RT   microtubule associated protein in mitosis.";
RL   Biochem. Biophys. Res. Commun. 429:57-62(2012).
RN   [53]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [54]
RP   FUNCTION, INTERACTION WITH TOM70, AND SUBCELLULAR LOCATION.
RX   PubMed=23911537; DOI=10.1016/j.bbamcr.2013.07.015;
RA   Kim Y., Kim H.D., Kim J.;
RT   "Cytoplasmic ribosomal protein S3 (rpS3) plays a pivotal role in
RT   mitochondrial DNA damage surveillance.";
RL   Biochim. Biophys. Acta 1833:2943-2952(2013).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; SER-104; THR-220 AND
RP   THR-221, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [56]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [57]
RP   INTERACTION WITH NFKBIA.
RX   PubMed=24457201; DOI=10.1016/j.febslet.2013.12.034;
RA   Stanborough T., Niederhauser J., Koch B., Bergler H., Pertschy B.;
RT   "Ribosomal protein S3 interacts with the NF-kappaB inhibitor
RT   IkappaBalpha.";
RL   FEBS Lett. 588:659-664(2014).
RN   [58]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-221 AND THR-242, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [59]
RP   INTERACTION WITH HNRPD.
RX   PubMed=24423872; DOI=10.1093/nar/gkt1379;
RA   Lee K.H., Kim S.H., Kim H.J., Kim W., Lee H.R., Jung Y., Choi J.H.,
RA   Hong K.Y., Jang S.K., Kim K.T.;
RT   "AUF1 contributes to Cryptochrome1 mRNA degradation and rhythmic
RT   translation.";
RL   Nucleic Acids Res. 42:3590-3606(2014).
RN   [60]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-230, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [61]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [62]
RP   UBIQUITINATION AT LYS-214.
RX   PubMed=28065601; DOI=10.1016/j.molcel.2016.11.039;
RA   Juszkiewicz S., Hegde R.S.;
RT   "Initiation of quality control during poly(A) translation requires site-
RT   specific ribosome ubiquitination.";
RL   Mol. Cell 65:743-750(2016).
RN   [63]
RP   UBIQUITINATION AT LYS-214.
RX   PubMed=28132843; DOI=10.1016/j.molcel.2016.12.026;
RA   Sundaramoorthy E., Leonard M., Mak R., Liao J., Fulzele A., Bennett E.J.;
RT   "ZNF598 and RACK1 regulate mammalian ribosome-associated quality control
RT   function by mediating regulatory 40S ribosomal ubiquitylation.";
RL   Mol. Cell 65:751-760(2017).
RN   [64]
RP   INTERACTION WITH ASCC3.
RX   PubMed=28757607; DOI=10.1038/s41467-017-00188-1;
RA   Matsuo Y., Ikeuchi K., Saeki Y., Iwasaki S., Schmidt C., Udagawa T.,
RA   Sato F., Tsuchiya H., Becker T., Tanaka K., Ingolia N.T., Beckmann R.,
RA   Inada T.;
RT   "Ubiquitination of stalled ribosome triggers ribosome-associated quality
RT   control.";
RL   Nat. Commun. 8:159-159(2017).
RN   [65]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-214 AND LYS-230, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [66]
RP   UBIQUITINATION AT LYS-214.
RX   PubMed=32011234; DOI=10.7554/elife.54023;
RA   Garshott D.M., Sundaramoorthy E., Leonard M., Bennett E.J.;
RT   "Distinct regulatory ribosomal ubiquitylation events are reversible and
RT   hierarchically organized.";
RL   Elife 9:0-0(2020).
RN   [67]
RP   UBIQUITINATION AT LYS-214, AND MUTAGENESIS OF LYS-214; LYS-227 AND LYS-230.
RX   PubMed=31981475; DOI=10.1016/j.molcel.2019.12.024;
RA   Meyer C., Garzia A., Morozov P., Molina H., Tuschl T.;
RT   "The G3BP1-family-USP10 deubiquitinase complex rescues ubiquitinated 40S
RT   subunits of ribosomes stalled in translation from lysosomal degradation.";
RL   Mol. Cell 77:1193-1205(2020).
RN   [68]
RP   UBIQUITINATION AT LYS-214, AND MUTAGENESIS OF LYS-214; LYS-227 AND LYS-230.
RX   PubMed=34348161; DOI=10.1016/j.celrep.2021.109468;
RA   Garzia A., Meyer C., Tuschl T.;
RT   "The E3 ubiquitin ligase RNF10 modifies 40S ribosomal subunits of ribosomes
RT   compromised in translation.";
RL   Cell Rep. 36:109468-109468(2021).
RN   [69]
RP   UBIQUITINATION AT LYS-214.
RX   PubMed=34469731; DOI=10.1016/j.celrep.2021.109642;
RA   Garshott D.M., An H., Sundaramoorthy E., Leonard M., Vicary A.,
RA   Harper J.W., Bennett E.J.;
RT   "iRQC, a surveillance pathway for 40S ribosomal quality control during mRNA
RT   translation initiation.";
RL   Cell Rep. 36:109642-109642(2021).
RN   [70]
RP   UBIQUITINATION AT LYS-214, AND MUTAGENESIS OF LYS-214.
RX   PubMed=39609413; DOI=10.1038/s41467-024-54411-x;
RA   Lehmann J.A., Lindner D., Sung H.M., Stoecklin G.;
RT   "E3 ubiquitin ligase RNF10 promotes dissociation of stalled ribosomes and
RT   responds to ribosomal subunit imbalance.";
RL   Nat. Commun. 15:10350-10350(2024).
RN   [71]
RP   UBIQUITINATION AT LYS-214, AND MUTAGENESIS OF LYS-214.
RX   PubMed=39947182; DOI=10.1016/j.molcel.2025.01.017;
RA   Coria A.R., Shah A., Shafieinouri M., Taylor S.J., Orgebin E., Guiblet W.,
RA   Miller J.T., Sharma I.M., Wu C.C.;
RT   "The integrated stress response regulates 18S nonfunctional rRNA decay in
RT   mammals.";
RL   Mol. Cell 85:787-801(2025).
RN   [72]
RP   STRUCTURE BY NMR OF 17-95.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the KH domain of human ribosomal protein S3.";
RL   Submitted (NOV-2004) to the PDB data bank.
RN   [73]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.0 ANGSTROMS) OF 80S RIBOSOME, FUNCTION,
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=23636399; DOI=10.1038/nature12104;
RA   Anger A.M., Armache J.P., Berninghausen O., Habeck M., Subklewe M.,
RA   Wilson D.N., Beckmann R.;
RT   "Structures of the human and Drosophila 80S ribosome.";
RL   Nature 497:80-85(2013).
RN   [74] {ECO:0007744|PDB:8ZDB, ECO:0007744|PDB:8ZDC, ECO:0007744|PDB:8ZDD}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) IN COMPLEX WITH 40S
RP   RIBOSOME AND RIOK3, INTERACTION WITH RIOK3, AND UBIQUITINATION AT LYS-214.
RX   PubMed=39947183; DOI=10.1016/j.molcel.2025.01.013;
RA   Huang Z., Diehl F.F., Wang M., Li Y., Song A., Chen F.X.,
RA   Rosa-Mercado N.A., Beckmann R., Green R., Cheng J.;
RT   "RIOK3 mediates the degradation of 40S ribosomes.";
RL   Mol. Cell 85:802-814(2025).
CC   -!- FUNCTION: Component of the small ribosomal subunit (PubMed:23636399,
CC       PubMed:8706699). The ribosome is a large ribonucleoprotein complex
CC       responsible for the synthesis of proteins in the cell (PubMed:23636399,
CC       PubMed:8706699). Has endonuclease activity and plays a role in repair
CC       of damaged DNA (PubMed:7775413). Cleaves phosphodiester bonds of DNAs
CC       containing altered bases with broad specificity and cleaves supercoiled
CC       DNA more efficiently than relaxed DNA (PubMed:15707971). Displays high
CC       binding affinity for 7,8-dihydro-8-oxoguanine (8-oxoG), a common DNA
CC       lesion caused by reactive oxygen species (ROS) (PubMed:14706345). Has
CC       also been shown to bind with similar affinity to intact and damaged DNA
CC       (PubMed:18610840). Stimulates the N-glycosylase activity of the base
CC       excision protein OGG1 (PubMed:15518571). Enhances the uracil excision
CC       activity of UNG1 (PubMed:18973764). Also stimulates the cleavage of the
CC       phosphodiester backbone by APEX1 (PubMed:18973764). When located in the
CC       mitochondrion, reduces cellular ROS levels and mitochondrial DNA damage
CC       (PubMed:23911537). Has also been shown to negatively regulate DNA
CC       repair in cells exposed to hydrogen peroxide (PubMed:17049931). Plays a
CC       role in regulating transcription as part of the NF-kappa-B p65-p50
CC       complex where it binds to the RELA/p65 subunit, enhances binding of the
CC       complex to DNA and promotes transcription of target genes
CC       (PubMed:18045535). Represses its own translation by binding to its
CC       cognate mRNA (PubMed:20217897). Binds to and protects TP53/p53 from
CC       MDM2-mediated ubiquitination (PubMed:19656744). Involved in spindle
CC       formation and chromosome movement during mitosis by regulating
CC       microtubule polymerization (PubMed:23131551). Involved in induction of
CC       apoptosis through its role in activation of CASP8 (PubMed:14988002).
CC       Induces neuronal apoptosis by interacting with the E2F1 transcription
CC       factor and acting synergistically with it to up-regulate pro-apoptotic
CC       proteins BCL2L11/BIM and HRK/Dp5 (PubMed:20605787). Interacts with
CC       TRADD following exposure to UV radiation and induces apoptosis by
CC       caspase-dependent JNK activation (PubMed:22510408).
CC       {ECO:0000269|PubMed:14706345, ECO:0000269|PubMed:14988002,
CC       ECO:0000269|PubMed:15518571, ECO:0000269|PubMed:15707971,
CC       ECO:0000269|PubMed:17049931, ECO:0000269|PubMed:18045535,
CC       ECO:0000269|PubMed:18610840, ECO:0000269|PubMed:18973764,
CC       ECO:0000269|PubMed:19656744, ECO:0000269|PubMed:20217897,
CC       ECO:0000269|PubMed:20605787, ECO:0000269|PubMed:22510408,
CC       ECO:0000269|PubMed:23131551, ECO:0000269|PubMed:23636399,
CC       ECO:0000269|PubMed:23911537, ECO:0000269|PubMed:7775413,
CC       ECO:0000269|PubMed:8706699}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2'-deoxyribonucleotide-(2'-deoxyribose 5'-phosphate)-2'-
CC         deoxyribonucleotide-DNA = a 3'-end 2'-deoxyribonucleotide-(2,3-
CC         dehydro-2,3-deoxyribose 5'-phosphate)-DNA + a 5'-end 5'-phospho-2'-
CC         deoxyribonucleoside-DNA + H(+); Xref=Rhea:RHEA:66592, Rhea:RHEA-
CC         COMP:13180, Rhea:RHEA-COMP:16897, Rhea:RHEA-COMP:17067,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:136412, ChEBI:CHEBI:157695,
CC         ChEBI:CHEBI:167181; EC=4.2.99.18;
CC         Evidence={ECO:0000269|PubMed:7775413};
CC   -!- ACTIVITY REGULATION: Endonuclease activity is inhibited by MgCl2 on
CC       apurinic/apyrimidinic DNA but not on UV-irradiated DNA.
CC       {ECO:0000269|PubMed:15707971}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is between 8.0 and 9.0 with activity decreasing sharply
CC         below 8.0. {ECO:0000269|PubMed:15707971};
CC   -!- SUBUNIT: Component of the 40S small ribosomal subunit (PubMed:23636399,
CC       PubMed:8706699). Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs (PubMed:17289661). Interacts with HNRPD
CC       (PubMed:24423872). Interacts with PRMT1; the interaction methylates
CC       RPS3 (PubMed:19460357). Interacts with SUMO1; the interaction
CC       sumoylates RPS3 (PubMed:21968017). Interacts with UBC9
CC       (PubMed:21968017). Interacts with CDK1; the interaction phosphorylates
CC       RPS3 (PubMed:21871177). Interacts with PRKCD; the interaction
CC       phosphorylates RPS3 (PubMed:19059439). Interacts with PKB/AKT; the
CC       interaction phosphorylates RPS3 (PubMed:20605787). Interacts with E2F1;
CC       the interaction occurs in the absence of nerve growth factor and
CC       increases transcription of pro-apoptotic proteins BCL2L11/BIM and
CC       HRK/Dp5 (PubMed:20605787). Interacts with the base excision repair
CC       proteins APEX1 and OGG1; interaction with OGG1 increases OGG1 N-
CC       glycosylase activity (PubMed:15518571). Interacts with UNG; the
CC       interaction increases the uracil excision activity of UNG1
CC       (PubMed:18973764). Interacts with HSP90; the interaction prevents the
CC       ubiquitination and proteasome-dependent degradation of RPS3 and is
CC       suppressed by increased ROS levels (PubMed:16314389). Interacts with
CC       TOM70; the interaction promotes translocation of RPS3 to the
CC       mitochondrion (PubMed:23911537). Interacts (via N-terminus) with RELA
CC       (via N-terminus); the interaction enhances the DNA-binding activity of
CC       the NF-kappa-B p65-p50 complex (PubMed:18045535). Interacts with
CC       NFKBIA; the interaction is direct and may bridge the interaction
CC       between RPS3 and RELA (PubMed:24457201). Interacts with IKKB; the
CC       interaction phosphorylates RPS3 and enhances its translocation to the
CC       nucleus (PubMed:21399639). Interacts (via KH domain) with MDM2 and TP53
CC       (PubMed:19656744). Interacts with TRADD (PubMed:22510408). Interacts
CC       (via N-terminus) with E.coli O157:H7 (strain EDL933) nleH1 and nleH2;
CC       the interaction with nleH1 inhibits phosphorylation by IKKB, reduces
CC       RPS3 nuclear abundance and inhibits transcriptional activation by the
CC       NF-kappa-B p65-p50 complex (PubMed:20041225, PubMed:21399639).
CC       Interacts with ASCC3 (PubMed:28757607). Identified in a HCV IRES-
CC       mediated translation complex, at least composed of EIF3C, IGF2BP1, RPS3
CC       and HCV RNA-replicon (PubMed:19541769). Interacts with CRY1 (By
CC       similarity). Interacts (when monoubiquitinated at Lys-214) with RIOK3
CC       (PubMed:39947182, PubMed:39947183). {ECO:0000250|UniProtKB:P62908,
CC       ECO:0000269|PubMed:15518571, ECO:0000269|PubMed:16314389,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:18045535,
CC       ECO:0000269|PubMed:18973764, ECO:0000269|PubMed:19059439,
CC       ECO:0000269|PubMed:19460357, ECO:0000269|PubMed:19541769,
CC       ECO:0000269|PubMed:19656744, ECO:0000269|PubMed:20041225,
CC       ECO:0000269|PubMed:20605787, ECO:0000269|PubMed:21399639,
CC       ECO:0000269|PubMed:21871177, ECO:0000269|PubMed:21968017,
CC       ECO:0000269|PubMed:22510408, ECO:0000269|PubMed:23636399,
CC       ECO:0000269|PubMed:23911537, ECO:0000269|PubMed:24423872,
CC       ECO:0000269|PubMed:24457201, ECO:0000269|PubMed:28757607,
CC       ECO:0000269|PubMed:39947182, ECO:0000269|PubMed:39947183,
CC       ECO:0000269|PubMed:8706699, ECO:0000303|PubMed:21399639}.
CC   -!- INTERACTION:
CC       P23396; P68400: CSNK2A1; NbExp=2; IntAct=EBI-351193, EBI-347804;
CC       P23396; P42858: HTT; NbExp=3; IntAct=EBI-351193, EBI-466029;
CC       P23396; O14920: IKBKB; NbExp=4; IntAct=EBI-351193, EBI-81266;
CC       P23396; Q5S007: LRRK2; NbExp=4; IntAct=EBI-351193, EBI-5323863;
CC       P23396; Q96GA3: LTV1; NbExp=6; IntAct=EBI-351193, EBI-2558389;
CC       P23396; Q00987: MDM2; NbExp=8; IntAct=EBI-351193, EBI-389668;
CC       P23396; Q15843: NEDD8; NbExp=3; IntAct=EBI-351193, EBI-716247;
CC       P23396; P19838: NFKB1; NbExp=5; IntAct=EBI-351193, EBI-300010;
CC       P23396; P25963: NFKBIA; NbExp=6; IntAct=EBI-351193, EBI-307386;
CC       P23396; Q08752: PPID; NbExp=4; IntAct=EBI-351193, EBI-716596;
CC       P23396; Q04206: RELA; NbExp=8; IntAct=EBI-351193, EBI-73886;
CC       P23396; P46783: RPS10; NbExp=4; IntAct=EBI-351193, EBI-354442;
CC       P23396; P04637: TP53; NbExp=4; IntAct=EBI-351193, EBI-366083;
CC       P23396; P63104: YWHAZ; NbExp=2; IntAct=EBI-351193, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16314389,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:17560175,
CC       ECO:0000269|PubMed:18045535, ECO:0000269|PubMed:20217897,
CC       ECO:0000269|PubMed:21871177, ECO:0000269|PubMed:23636399}. Nucleus
CC       {ECO:0000269|PubMed:17560175, ECO:0000269|PubMed:18045535,
CC       ECO:0000269|PubMed:19460357, ECO:0000269|PubMed:20217897,
CC       ECO:0000269|PubMed:21871177}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:16314389, ECO:0000269|PubMed:19460357}.
CC       Mitochondrion inner membrane {ECO:0000269|PubMed:23911537}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:23911537}. Cytoplasm,
CC       cytoskeleton, spindle {ECO:0000269|PubMed:23131551}. Note=In normal
CC       cells, located mainly in the cytoplasm with small amounts in the
CC       nucleus but translocates to the nucleus in cells undergoing apoptosis
CC       (By similarity). Nuclear translocation is induced by DNA damaging
CC       agents such as hydrogen peroxide (PubMed:17560175). Accumulates in the
CC       mitochondrion in response to increased ROS levels (PubMed:23911537).
CC       Localizes to the spindle during mitosis (PubMed:23131551). Localized in
CC       cytoplasmic mRNP granules containing untranslated mRNAs
CC       (PubMed:17289661). {ECO:0000250|UniProtKB:P62908,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:17560175,
CC       ECO:0000269|PubMed:23131551, ECO:0000269|PubMed:23911537}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P23396-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P23396-2; Sequence=VSP_046667;
CC   -!- PTM: Methylation by PRMT1 is required for import into the nucleolus and
CC       for ribosome assembly. {ECO:0000269|PubMed:19460357}.
CC   -!- PTM: Sumoylation by SUMO1 enhances protein stability through increased
CC       resistance to proteolysis. Sumoylation occurs at one or more of the
CC       three consensus sites, Lys-18, Lys-214 and Lys-230.
CC       {ECO:0000269|PubMed:21968017}.
CC   -!- PTM: Phosphorylation at Thr-221 by CDK1 occurs mainly in G2/M phase
CC       (PubMed:21871177). Phosphorylation by PRKCD occurs on a non-ribosomal-
CC       associated form which results in translocation of RPS3 to the nucleus
CC       and enhances its endonuclease activity (PubMed:19059439).
CC       Phosphorylated on Ser-209 by IKKB in response to activation of the NF-
CC       kappa-B p65-p50 complex which enhances the association of RPS3 with
CC       importin-alpha and mediates the nuclear translocation of RPS3
CC       (PubMed:21399639). Phosphorylation by MAPK is required for
CC       translocation to the nucleus following exposure of cells to DNA
CC       damaging agents such as hydrogen peroxide (PubMed:17560175).
CC       Phosphorylation by PKB/AKT mediates RPS3 nuclear translocation,
CC       enhances RPS3 endonuclease activity and suppresses RPS3-induced
CC       neuronal apoptosis (PubMed:20605787). {ECO:0000269|PubMed:17560175,
CC       ECO:0000269|PubMed:19059439, ECO:0000269|PubMed:20605787,
CC       ECO:0000269|PubMed:21399639, ECO:0000269|PubMed:21871177}.
CC   -!- PTM: Ubiquitinated; ubiquitination is prevented by interaction with
CC       HSP90 which stabilizes the protein (PubMed:16314389). Monoubiquitinated
CC       at Lys-214 by RNF10 and ZNF598 when a ribosome has stalled during
CC       translation of poly(A) sequences, leading to preclude synthesis of a
CC       long poly-lysine tail and initiate the ribosome quality control (RQC)
CC       pathway to degrade the potentially detrimental aberrant nascent
CC       polypeptide (PubMed:28065601, PubMed:28132843, PubMed:32011234,
CC       PubMed:34348161, PubMed:34469731, PubMed:39609413, PubMed:39947182,
CC       PubMed:39947183). Monoubiquitination at Lys-214 promotes interaction
CC       with RIOK3 (PubMed:39947182, PubMed:39947183). Deubiquitinated at Lys-
CC       214 by USP10, preventing degradation by the proteasome and promoting
CC       40S ribosome subunit recycling following ribosome dissociation
CC       (PubMed:31981475, PubMed:34469731). {ECO:0000269|PubMed:16314389,
CC       ECO:0000269|PubMed:28065601, ECO:0000269|PubMed:28132843,
CC       ECO:0000269|PubMed:31981475, ECO:0000269|PubMed:32011234,
CC       ECO:0000269|PubMed:34348161, ECO:0000269|PubMed:34469731,
CC       ECO:0000269|PubMed:39609413, ECO:0000269|PubMed:39947182,
CC       ECO:0000269|PubMed:39947183}.
CC   -!- PTM: Ufmylated by UFL1. {ECO:0000250|UniProtKB:P62908}.
CC   -!- SIMILARITY: Belongs to the universal ribosomal protein uS3 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB93471.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U14990; AAB60336.1; -; mRNA.
DR   EMBL; U14991; AAB60337.1; -; mRNA.
DR   EMBL; U14992; AAB60338.1; -; mRNA.
DR   EMBL; X55715; CAA39248.1; -; mRNA.
DR   EMBL; S42658; AAB19349.2; -; mRNA.
DR   EMBL; AB061838; BAB79476.1; -; Genomic_DNA.
DR   EMBL; AY791291; AAV40835.1; -; Genomic_DNA.
DR   EMBL; AK313051; BAG35882.1; -; mRNA.
DR   EMBL; AP000744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74963.1; -; Genomic_DNA.
DR   EMBL; BC003137; AAH03137.1; -; mRNA.
DR   EMBL; BC003577; AAH03577.1; -; mRNA.
DR   EMBL; BC013196; AAH13196.1; -; mRNA.
DR   EMBL; BC034149; AAH34149.1; -; mRNA.
DR   EMBL; BC071917; AAH71917.1; -; mRNA.
DR   EMBL; BC100284; AAI00285.1; -; mRNA.
DR   EMBL; L16016; AAA18095.1; -; Genomic_DNA.
DR   EMBL; AB062288; BAB93471.1; ALT_INIT; mRNA.
DR   CCDS; CCDS58161.1; -. [P23396-2]
DR   CCDS; CCDS8236.1; -. [P23396-1]
DR   PIR; A41247; R3HUS3.
DR   RefSeq; NP_000996.2; NM_001005.4. [P23396-1]
DR   RefSeq; NP_001243731.1; NM_001256802.2. [P23396-1]
DR   RefSeq; NP_001247435.1; NM_001260506.2. [P23396-2]
DR   RefSeq; NP_001247436.1; NM_001260507.1.
DR   PDB; 1WH9; NMR; -; A=17-95.
DR   PDB; 4UG0; EM; -; SD=1-243.
DR   PDB; 4V6X; EM; 5.00 A; AD=1-243.
DR   PDB; 5A2Q; EM; 3.90 A; D=1-243.
DR   PDB; 5AJ0; EM; 3.50 A; BD=1-243.
DR   PDB; 5FLX; EM; 3.90 A; D=1-243.
DR   PDB; 5LKS; EM; 3.60 A; SD=1-243.
DR   PDB; 5OA3; EM; 4.30 A; D=1-243.
DR   PDB; 5T2C; EM; 3.60 A; Aq=1-243.
DR   PDB; 5VYC; X-ray; 6.00 A; D1/D2/D3/D4/D5/D6=1-243.
DR   PDB; 6FEC; EM; 6.30 A; g=1-227.
DR   PDB; 6G51; EM; 4.10 A; D=1-243.
DR   PDB; 6G53; EM; 4.50 A; D=1-243.
DR   PDB; 6G5H; EM; 3.60 A; D=1-243.
DR   PDB; 6G5I; EM; 3.50 A; D=1-243.
DR   PDB; 6IP5; EM; 3.90 A; 2p=1-243.
DR   PDB; 6IP6; EM; 4.50 A; 2p=1-243.
DR   PDB; 6IP8; EM; 3.90 A; 2p=1-243.
DR   PDB; 6OLE; EM; 3.10 A; SD=2-227.
DR   PDB; 6OLF; EM; 3.90 A; SD=2-227.
DR   PDB; 6OLG; EM; 3.40 A; BD=2-221.
DR   PDB; 6OLI; EM; 3.50 A; SD=2-227.
DR   PDB; 6OLZ; EM; 3.90 A; BD=2-221.
DR   PDB; 6OM0; EM; 3.10 A; SD=2-227.
DR   PDB; 6OM7; EM; 3.70 A; SD=2-227.
DR   PDB; 6QZP; EM; 2.90 A; SD=1-227.
DR   PDB; 6XA1; EM; 2.80 A; SD=4-227.
DR   PDB; 6Y0G; EM; 3.20 A; SD=1-243.
DR   PDB; 6Y2L; EM; 3.00 A; SD=1-243.
DR   PDB; 6Y57; EM; 3.50 A; SD=1-243.
DR   PDB; 6YBS; EM; 3.10 A; Z=1-243.
DR   PDB; 6Z6L; EM; 3.00 A; SD=1-243.
DR   PDB; 6Z6M; EM; 3.10 A; SD=1-243.
DR   PDB; 6Z6N; EM; 2.90 A; SD=1-243.
DR   PDB; 6ZLW; EM; 2.60 A; F=1-243.
DR   PDB; 6ZM7; EM; 2.70 A; SD=1-243.
DR   PDB; 6ZME; EM; 3.00 A; SD=1-243.
DR   PDB; 6ZMI; EM; 2.60 A; SD=1-243.
DR   PDB; 6ZMO; EM; 3.10 A; SD=1-243.
DR   PDB; 6ZMT; EM; 3.00 A; F=1-243.
DR   PDB; 6ZMW; EM; 3.70 A; Z=1-243.
DR   PDB; 6ZN5; EM; 3.20 A; F=3-227.
DR   PDB; 6ZOJ; EM; 2.80 A; D=1-243.
DR   PDB; 6ZOL; EM; 2.80 A; D=1-243.
DR   PDB; 6ZON; EM; 3.00 A; b=1-243.
DR   PDB; 6ZP4; EM; 2.90 A; b=1-243.
DR   PDB; 6ZUO; EM; 3.10 A; D=1-243.
DR   PDB; 6ZV6; EM; 2.90 A; D=1-243.
DR   PDB; 6ZVH; EM; 2.90 A; D=1-227.
DR   PDB; 6ZVJ; EM; 3.80 A; b=4-227.
DR   PDB; 6ZXD; EM; 3.20 A; D=1-243.
DR   PDB; 6ZXE; EM; 3.00 A; D=1-243.
DR   PDB; 6ZXF; EM; 3.70 A; D=1-243.
DR   PDB; 6ZXG; EM; 2.60 A; D=1-243.
DR   PDB; 6ZXH; EM; 2.70 A; D=1-243.
DR   PDB; 7A09; EM; 3.50 A; b=1-243.
DR   PDB; 7K5I; EM; 2.90 A; D=1-243.
DR   PDB; 7QP6; EM; 4.70 A; Z=1-243.
DR   PDB; 7QP7; EM; 3.70 A; Z=1-243.
DR   PDB; 7QVP; EM; 3.00 A; RD/SD=1-243.
DR   PDB; 7R4X; EM; 2.15 A; D=1-243.
DR   PDB; 7TQL; EM; 3.40 A; F=3-227.
DR   PDB; 7XNX; EM; 2.70 A; SD=1-243.
DR   PDB; 7XNY; EM; 2.50 A; SD=1-243.
DR   PDB; 8G5Y; EM; 2.29 A; SD=1-243.
DR   PDB; 8G5Z; EM; 2.64 A; SD=1-226.
DR   PDB; 8G60; EM; 2.54 A; SD=1-243.
DR   PDB; 8G61; EM; 2.94 A; SD=1-243.
DR   PDB; 8G6J; EM; 2.80 A; SD=1-243.
DR   PDB; 8GLP; EM; 1.67 A; SD=1-243.
DR   PDB; 8IFD; EM; 2.59 A; 2p=1-243.
DR   PDB; 8IFE; EM; 2.57 A; 2p=1-243.
DR   PDB; 8JDJ; EM; 2.50 A; 0=1-243.
DR   PDB; 8JDK; EM; 2.26 A; 0=1-243.
DR   PDB; 8JDL; EM; 2.42 A; 0=1-243.
DR   PDB; 8JDM; EM; 2.67 A; 0=1-243.
DR   PDB; 8K2C; EM; 2.40 A; SD=1-243.
DR   PDB; 8OZ0; EM; 3.50 A; h=1-243.
DR   PDB; 8PJ1; EM; 3.40 A; Z=1-243.
DR   PDB; 8PJ2; EM; 3.40 A; Z=1-243.
DR   PDB; 8PJ3; EM; 3.70 A; Z=1-243.
DR   PDB; 8PJ4; EM; 3.20 A; Z=1-243.
DR   PDB; 8PJ5; EM; 2.90 A; Z=1-243.
DR   PDB; 8PJ6; EM; 2.90 A; Z=1-243.
DR   PDB; 8PPK; EM; 2.98 A; D=1-243.
DR   PDB; 8PPL; EM; 2.65 A; AD=1-243.
DR   PDB; 8QOI; EM; 1.90 A; SD=1-243.
DR   PDB; 8T4S; EM; 2.60 A; D=1-243.
DR   PDB; 8UIK; EM; 2.96 A; SD=1-227.
DR   PDB; 8UIY; EM; 2.97 A; SD=1-227.
DR   PDB; 8UIZ; EM; 3.43 A; SD=1-227.
DR   PDB; 8UJ9; EM; 3.64 A; SD=1-227.
DR   PDB; 8UJB; EM; 2.67 A; SD=1-227.
DR   PDB; 8UJJ; EM; 3.56 A; SD=1-227.
DR   PDB; 8UJK; EM; 3.54 A; SD=1-227.
DR   PDB; 8UKB; EM; 3.05 A; SD=1-227.
DR   PDB; 8XP2; EM; 3.20 A; SD=1-243.
DR   PDB; 8XP3; EM; 3.40 A; SD=1-243.
DR   PDB; 8XSX; EM; 2.40 A; SD=1-243.
DR   PDB; 8XSY; EM; 3.00 A; SD=1-243.
DR   PDB; 8XSZ; EM; 3.20 A; SD=1-243.
DR   PDB; 8XXL; EM; 2.90 A; SD=1-243.
DR   PDB; 8XXM; EM; 3.20 A; SD=1-243.
DR   PDB; 8XXN; EM; 3.60 A; SD=1-243.
DR   PDB; 8Y0W; EM; 3.40 A; SD=1-243.
DR   PDB; 8Y0X; EM; 3.30 A; SD=1-243.
DR   PDB; 8YOO; EM; 2.00 A; SD=1-243.
DR   PDB; 8YOP; EM; 2.20 A; SD=1-243.
DR   PDB; 8ZDB; EM; 3.60 A; D=1-243.
DR   PDB; 8ZDC; EM; 3.80 A; D=1-243.
DR   PDB; 8ZDD; EM; 3.70 A; D=1-243.
DR   PDB; 9AZC; EM; 2.19 A; SD=1-227.
DR   PDB; 9AZM; EM; 2.68 A; SD=1-227.
DR   PDB; 9AZN; EM; 2.98 A; SD=1-227.
DR   PDB; 9AZS; EM; 2.80 A; SD=1-227.
DR   PDB; 9B0F; EM; 2.78 A; SD=1-227.
DR   PDB; 9B0G; EM; 2.57 A; SD=1-227.
DR   PDB; 9B0H; EM; 2.59 A; SD=1-227.
DR   PDB; 9B0J; EM; 2.84 A; SD=1-227.
DR   PDB; 9B0N; EM; 2.92 A; SD=1-227.
DR   PDB; 9B0O; EM; 2.83 A; SD=1-227.
DR   PDB; 9B0P; EM; 2.82 A; SD=1-227.
DR   PDB; 9B0Q; EM; 3.20 A; SD/sD=1-227.
DR   PDB; 9B0R; EM; 2.81 A; SD=1-227.
DR   PDB; 9B0S; EM; 3.80 A; SD/sD=1-227.
DR   PDB; 9B0W; EM; 2.66 A; SD=1-227.
DR   PDB; 9B11; EM; 2.77 A; SD=1-227.
DR   PDB; 9BKD; EM; 2.60 A; Z=1-243.
DR   PDB; 9BLN; EM; 3.90 A; Z=1-243.
DR   PDB; 9C3H; EM; 2.00 A; SK=1-243.
DR   PDB; 9ED0; EM; 2.80 A; D=1-243.
DR   PDB; 9G8M; EM; 3.30 A; SD=1-243.
DR   PDB; 9G8O; EM; 3.40 A; SD=1-243.
DR   PDBsum; 1WH9; -.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5A2Q; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5FLX; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5OA3; -.
DR   PDBsum; 5T2C; -.
DR   PDBsum; 5VYC; -.
DR   PDBsum; 6FEC; -.
DR   PDBsum; 6G51; -.
DR   PDBsum; 6G53; -.
DR   PDBsum; 6G5H; -.
DR   PDBsum; 6G5I; -.
DR   PDBsum; 6IP5; -.
DR   PDBsum; 6IP6; -.
DR   PDBsum; 6IP8; -.
DR   PDBsum; 6OLE; -.
DR   PDBsum; 6OLF; -.
DR   PDBsum; 6OLG; -.
DR   PDBsum; 6OLI; -.
DR   PDBsum; 6OLZ; -.
DR   PDBsum; 6OM0; -.
DR   PDBsum; 6OM7; -.
DR   PDBsum; 6QZP; -.
DR   PDBsum; 6XA1; -.
DR   PDBsum; 6Y0G; -.
DR   PDBsum; 6Y2L; -.
DR   PDBsum; 6Y57; -.
DR   PDBsum; 6YBS; -.
DR   PDBsum; 6Z6L; -.
DR   PDBsum; 6Z6M; -.
DR   PDBsum; 6Z6N; -.
DR   PDBsum; 6ZLW; -.
DR   PDBsum; 6ZM7; -.
DR   PDBsum; 6ZME; -.
DR   PDBsum; 6ZMI; -.
DR   PDBsum; 6ZMO; -.
DR   PDBsum; 6ZMT; -.
DR   PDBsum; 6ZMW; -.
DR   PDBsum; 6ZN5; -.
DR   PDBsum; 6ZOJ; -.
DR   PDBsum; 6ZOL; -.
DR   PDBsum; 6ZON; -.
DR   PDBsum; 6ZP4; -.
DR   PDBsum; 6ZUO; -.
DR   PDBsum; 6ZV6; -.
DR   PDBsum; 6ZVH; -.
DR   PDBsum; 6ZVJ; -.
DR   PDBsum; 6ZXD; -.
DR   PDBsum; 6ZXE; -.
DR   PDBsum; 6ZXF; -.
DR   PDBsum; 6ZXG; -.
DR   PDBsum; 6ZXH; -.
DR   PDBsum; 7A09; -.
DR   PDBsum; 7K5I; -.
DR   PDBsum; 7QP6; -.
DR   PDBsum; 7QP7; -.
DR   PDBsum; 7QVP; -.
DR   PDBsum; 7R4X; -.
DR   PDBsum; 7TQL; -.
DR   PDBsum; 7XNX; -.
DR   PDBsum; 7XNY; -.
DR   PDBsum; 8G5Y; -.
DR   PDBsum; 8G5Z; -.
DR   PDBsum; 8G60; -.
DR   PDBsum; 8G61; -.
DR   PDBsum; 8G6J; -.
DR   PDBsum; 8GLP; -.
DR   PDBsum; 8IFD; -.
DR   PDBsum; 8IFE; -.
DR   PDBsum; 8JDJ; -.
DR   PDBsum; 8JDK; -.
DR   PDBsum; 8JDL; -.
DR   PDBsum; 8JDM; -.
DR   PDBsum; 8K2C; -.
DR   PDBsum; 8OZ0; -.
DR   PDBsum; 8PJ1; -.
DR   PDBsum; 8PJ2; -.
DR   PDBsum; 8PJ3; -.
DR   PDBsum; 8PJ4; -.
DR   PDBsum; 8PJ5; -.
DR   PDBsum; 8PJ6; -.
DR   PDBsum; 8PPK; -.
DR   PDBsum; 8PPL; -.
DR   PDBsum; 8QOI; -.
DR   PDBsum; 8T4S; -.
DR   PDBsum; 8UIK; -.
DR   PDBsum; 8UIY; -.
DR   PDBsum; 8UIZ; -.
DR   PDBsum; 8UJ9; -.
DR   PDBsum; 8UJB; -.
DR   PDBsum; 8UJJ; -.
DR   PDBsum; 8UJK; -.
DR   PDBsum; 8UKB; -.
DR   PDBsum; 8XP2; -.
DR   PDBsum; 8XP3; -.
DR   PDBsum; 8XSX; -.
DR   PDBsum; 8XSY; -.
DR   PDBsum; 8XSZ; -.
DR   PDBsum; 8XXL; -.
DR   PDBsum; 8XXM; -.
DR   PDBsum; 8XXN; -.
DR   PDBsum; 8Y0W; -.
DR   PDBsum; 8Y0X; -.
DR   PDBsum; 8YOO; -.
DR   PDBsum; 8YOP; -.
DR   PDBsum; 8ZDB; -.
DR   PDBsum; 8ZDC; -.
DR   PDBsum; 8ZDD; -.
DR   PDBsum; 9AZC; -.
DR   PDBsum; 9AZM; -.
DR   PDBsum; 9AZN; -.
DR   PDBsum; 9AZS; -.
DR   PDBsum; 9B0F; -.
DR   PDBsum; 9B0G; -.
DR   PDBsum; 9B0H; -.
DR   PDBsum; 9B0J; -.
DR   PDBsum; 9B0N; -.
DR   PDBsum; 9B0O; -.
DR   PDBsum; 9B0P; -.
DR   PDBsum; 9B0Q; -.
DR   PDBsum; 9B0R; -.
DR   PDBsum; 9B0S; -.
DR   PDBsum; 9B0W; -.
DR   PDBsum; 9B11; -.
DR   PDBsum; 9BKD; -.
DR   PDBsum; 9BLN; -.
DR   PDBsum; 9C3H; -.
DR   PDBsum; 9ED0; -.
DR   PDBsum; 9G8M; -.
DR   PDBsum; 9G8O; -.
DR   AlphaFoldDB; P23396; -.
DR   BMRB; P23396; -.
DR   EMDB; EMD-10668; -.
DR   EMDB; EMD-10674; -.
DR   EMDB; EMD-10690; -.
DR   EMDB; EMD-10772; -.
DR   EMDB; EMD-11098; -.
DR   EMDB; EMD-11099; -.
DR   EMDB; EMD-11100; -.
DR   EMDB; EMD-11276; -.
DR   EMDB; EMD-11288; -.
DR   EMDB; EMD-11289; -.
DR   EMDB; EMD-11292; -.
DR   EMDB; EMD-11299; -.
DR   EMDB; EMD-11301; -.
DR   EMDB; EMD-11302; -.
DR   EMDB; EMD-11310; -.
DR   EMDB; EMD-11320; -.
DR   EMDB; EMD-11322; -.
DR   EMDB; EMD-11325; -.
DR   EMDB; EMD-11335; -.
DR   EMDB; EMD-11440; -.
DR   EMDB; EMD-11441; -.
DR   EMDB; EMD-11456; -.
DR   EMDB; EMD-11458; -.
DR   EMDB; EMD-11517; -.
DR   EMDB; EMD-11518; -.
DR   EMDB; EMD-11519; -.
DR   EMDB; EMD-11520; -.
DR   EMDB; EMD-11521; -.
DR   EMDB; EMD-11602; -.
DR   EMDB; EMD-14113; -.
DR   EMDB; EMD-14114; -.
DR   EMDB; EMD-14181; -.
DR   EMDB; EMD-14317; -.
DR   EMDB; EMD-17297; -.
DR   EMDB; EMD-17696; -.
DR   EMDB; EMD-17697; -.
DR   EMDB; EMD-17698; -.
DR   EMDB; EMD-17699; -.
DR   EMDB; EMD-17700; -.
DR   EMDB; EMD-17701; -.
DR   EMDB; EMD-17804; -.
DR   EMDB; EMD-17805; -.
DR   EMDB; EMD-18539; -.
DR   EMDB; EMD-22681; -.
DR   EMDB; EMD-26067; -.
DR   EMDB; EMD-29757; -.
DR   EMDB; EMD-29758; -.
DR   EMDB; EMD-29759; -.
DR   EMDB; EMD-29760; -.
DR   EMDB; EMD-29771; -.
DR   EMDB; EMD-33329; -.
DR   EMDB; EMD-33330; -.
DR   EMDB; EMD-35413; -.
DR   EMDB; EMD-35414; -.
DR   EMDB; EMD-36178; -.
DR   EMDB; EMD-36179; -.
DR   EMDB; EMD-36180; -.
DR   EMDB; EMD-36181; -.
DR   EMDB; EMD-36838; -.
DR   EMDB; EMD-3770; -.
DR   EMDB; EMD-38548; -.
DR   EMDB; EMD-38549; -.
DR   EMDB; EMD-38629; -.
DR   EMDB; EMD-38630; -.
DR   EMDB; EMD-38631; -.
DR   EMDB; EMD-38752; -.
DR   EMDB; EMD-38753; -.
DR   EMDB; EMD-38754; -.
DR   EMDB; EMD-3883; -.
DR   EMDB; EMD-39455; -.
DR   EMDB; EMD-39456; -.
DR   EMDB; EMD-39956; -.
DR   EMDB; EMD-39957; -.
DR   EMDB; EMD-39958; -.
DR   EMDB; EMD-40205; -.
DR   EMDB; EMD-4070; -.
DR   EMDB; EMD-41039; -.
DR   EMDB; EMD-42297; -.
DR   EMDB; EMD-42305; -.
DR   EMDB; EMD-42306; -.
DR   EMDB; EMD-42316; -.
DR   EMDB; EMD-42317; -.
DR   EMDB; EMD-42320; -.
DR   EMDB; EMD-42321; -.
DR   EMDB; EMD-42351; -.
DR   EMDB; EMD-4242; -.
DR   EMDB; EMD-4350; -.
DR   EMDB; EMD-4351; -.
DR   EMDB; EMD-4352; -.
DR   EMDB; EMD-4353; -.
DR   EMDB; EMD-44014; -.
DR   EMDB; EMD-44016; -.
DR   EMDB; EMD-44017; -.
DR   EMDB; EMD-44021; -.
DR   EMDB; EMD-44039; -.
DR   EMDB; EMD-44040; -.
DR   EMDB; EMD-44041; -.
DR   EMDB; EMD-44043; -.
DR   EMDB; EMD-44047; -.
DR   EMDB; EMD-44048; -.
DR   EMDB; EMD-44049; -.
DR   EMDB; EMD-44050; -.
DR   EMDB; EMD-44051; -.
DR   EMDB; EMD-44052; -.
DR   EMDB; EMD-44060; -.
DR   EMDB; EMD-44063; -.
DR   EMDB; EMD-44641; -.
DR   EMDB; EMD-44671; -.
DR   EMDB; EMD-45170; -.
DR   EMDB; EMD-47929; -.
DR   EMDB; EMD-51132; -.
DR   EMDB; EMD-51134; -.
DR   EMDB; EMD-9701; -.
DR   EMDB; EMD-9702; -.
DR   EMDB; EMD-9703; -.
DR   SMR; P23396; -.
DR   BioGRID; 112102; 888.
DR   ComplexPortal; CPX-5223; 40S cytosolic small ribosomal subunit.
DR   CORUM; P23396; -.
DR   DIP; DIP-33177N; -.
DR   ELM; P23396; -.
DR   FunCoup; P23396; 2608.
DR   IntAct; P23396; 701.
DR   MINT; P23396; -.
DR   STRING; 9606.ENSP00000278572; -.
DR   MoonProt; P23396; -.
DR   GlyGen; P23396; 3 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; P23396; -.
DR   MetOSite; P23396; -.
DR   PhosphoSitePlus; P23396; -.
DR   SwissPalm; P23396; -.
DR   BioMuta; RPS3; -.
DR   DMDM; 417719; -.
DR   jPOST; P23396; -.
DR   MassIVE; P23396; -.
DR   PaxDb; 9606-ENSP00000278572; -.
DR   PeptideAtlas; P23396; -.
DR   PRIDE; P23396; -.
DR   ProteomicsDB; 54087; -. [P23396-1]
DR   Pumba; P23396; -.
DR   Antibodypedia; 31150; 354 antibodies from 37 providers.
DR   DNASU; 6188; -.
DR   Ensembl; ENST00000278572.10; ENSP00000278572.6; ENSG00000149273.16. [P23396-2]
DR   Ensembl; ENST00000524851.5; ENSP00000433821.1; ENSG00000149273.16. [P23396-1]
DR   Ensembl; ENST00000527446.5; ENSP00000436971.1; ENSG00000149273.16. [P23396-1]
DR   Ensembl; ENST00000531188.6; ENSP00000434643.1; ENSG00000149273.16. [P23396-1]
DR   GeneID; 6188; -.
DR   KEGG; hsa:6188; -.
DR   MANE-Select; ENST00000531188.6; ENSP00000434643.1; NM_001005.5; NP_000996.2.
DR   UCSC; uc001owh.5; human. [P23396-1]
DR   AGR; HGNC:10420; -.
DR   ClinPGx; PA34829; -.
DR   CTD; 6188; -.
DR   DisGeNET; 6188; -.
DR   GeneCards; RPS3; -.
DR   HGNC; HGNC:10420; RPS3.
DR   HPA; ENSG00000149273; Low tissue specificity.
DR   MIM; 600454; gene.
DR   OpenTargets; ENSG00000149273; -.
DR   VEuPathDB; HostDB:ENSG00000149273; -.
DR   eggNOG; KOG3181; Eukaryota.
DR   GeneTree; ENSGT00390000008610; -.
DR   HOGENOM; CLU_058591_2_1_1; -.
DR   InParanoid; P23396; -.
DR   OMA; NKKKWMI; -.
DR   OrthoDB; 10248446at2759; -.
DR   PAN-GO; P23396; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; P23396; -.
DR   PathwayCommons; P23396; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-9735869; SARS-CoV-1 modulates host translation machinery.
DR   Reactome; R-HSA-9754678; SARS-CoV-2 modulates host translation machinery.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; P23396; -.
DR   SIGNOR; P23396; -.
DR   Agora; ENSG00000149273; -.
DR   BioGRID-ORCS; 6188; 823 hits in 1124 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; F85A2E29; IMP1 RNP granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; RPS3; human.
DR   EvolutionaryTrace; P23396; -.
DR   GeneWiki; RPS3; -.
DR   GenomeRNAi; 6188; -.
DR   Pharos; P23396; Tbio.
DR   PRO; PR:P23396; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P23396; protein.
DR   Bgee; ENSG00000149273; Expressed in left ovary and 104 other cell types or tissues.
DR   ExpressionAtlas; P23396; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0022626; C:cytosolic ribosome; IDA:FlyBase.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0071159; C:NF-kappaB complex; IDA:CAFA.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0005840; C:ribosome; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IDA:UniProtKB.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0004520; F:DNA endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003906; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IMP:UniProtKB.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IDA:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:UniProtKB.
DR   GO; GO:0051536; F:iron-sulfur cluster binding; NAS:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0032357; F:oxidized purine DNA binding; IDA:UniProtKB.
DR   GO; GO:0032358; F:oxidized pyrimidine DNA binding; IDA:UniProtKB.
DR   GO; GO:0051018; F:protein kinase A binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0070181; F:small ribosomal subunit rRNA binding; IDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; IDA:FlyBase.
DR   GO; GO:0097100; F:supercoiled DNA binding; IDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; IDA:UniProtKB.
DR   GO; GO:0044390; F:ubiquitin-like protein conjugating enzyme binding; IPI:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006284; P:base-excision repair; IDA:GO_Central.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0002181; P:cytoplasmic translation; NAS:UniProtKB.
DR   GO; GO:0002183; P:cytoplasmic translational initiation; NAS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; IEP:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IMP:UniProtKB.
DR   GO; GO:0045738; P:negative regulation of DNA repair; IMP:UniProtKB.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0017148; P:negative regulation of translation; IDA:UniProtKB.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:1905053; P:positive regulation of base-excision repair; IDA:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB.
DR   GO; GO:2000144; P:positive regulation of DNA-templated transcription initiation; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:1902231; P:positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage; IMP:UniProtKB.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0061481; P:response to TNF agonist; IDA:UniProtKB.
DR   GO; GO:0051225; P:spindle assembly; IMP:UniProtKB.
DR   CDD; cd02413; KH-II_40S_S3; 1.
DR   FunFam; 3.30.1140.32:FF:000005; 40S ribosomal protein S3; 1.
DR   FunFam; 3.30.300.20:FF:000006; 40S ribosomal protein S3; 1.
DR   Gene3D; 3.30.300.20; -; 1.
DR   Gene3D; 3.30.1140.32; Ribosomal protein S3, C-terminal domain; 1.
DR   InterPro; IPR015946; KH_dom-like_a/b.
DR   InterPro; IPR004044; KH_dom_type_2.
DR   InterPro; IPR009019; KH_sf_prok-type.
DR   InterPro; IPR036419; Ribosomal_S3_C_sf.
DR   InterPro; IPR057258; Ribosomal_uS3.
DR   InterPro; IPR001351; Ribosomal_uS3_C.
DR   InterPro; IPR018280; Ribosomal_uS3_CS.
DR   InterPro; IPR005703; Ribosomal_uS3_euk/arc.
DR   NCBIfam; NF003219; PRK04191.1; 1.
DR   NCBIfam; TIGR01008; uS3_euk_arch; 1.
DR   PANTHER; PTHR11760; 30S/40S RIBOSOMAL PROTEIN S3; 1.
DR   PANTHER; PTHR11760:SF32; SMALL RIBOSOMAL SUBUNIT PROTEIN US3; 1.
DR   Pfam; PF07650; KH_2; 1.
DR   Pfam; PF00189; Ribosomal_S3_C; 1.
DR   SUPFAM; SSF54814; Prokaryotic type KH domain (KH-domain type II); 1.
DR   SUPFAM; SSF54821; Ribosomal protein S3 C-terminal domain; 1.
DR   PROSITE; PS50823; KH_TYPE_2; 1.
DR   PROSITE; PS00548; RIBOSOMAL_S3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Cell cycle;
KW   Cell division; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   DNA damage; DNA repair; DNA-binding; Isopeptide bond; Lyase; Membrane;
KW   Methylation; Mitochondrion; Mitochondrion inner membrane; Mitosis; Nucleus;
KW   Phosphoprotein; Proteomics identification; Reference proteome;
KW   Ribonucleoprotein; Ribosomal protein; RNA-binding; Transcription;
KW   Transcription regulation; Translation regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   CHAIN           2..243
FT                   /note="Small ribosomal subunit protein uS3"
FT                   /id="PRO_0000130320"
FT   DOMAIN          21..92
FT                   /note="KH type-2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00118"
FT   REGION          214..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        231..243
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378, ECO:0007744|PubMed:25944712"
FT   MOD_RES         6
FT                   /note="Phosphoserine; by PKC/PRKCD"
FT                   /evidence="ECO:0000269|PubMed:19059439"
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         42
FT                   /note="Phosphothreonine; by MAPK"
FT                   /evidence="ECO:0000269|PubMed:15950189"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         64
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:19460357"
FT   MOD_RES         65
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:19460357"
FT   MOD_RES         67
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:19460357"
FT   MOD_RES         70
FT                   /note="Phosphothreonine; by PKB"
FT                   /evidence="ECO:0000269|PubMed:20605787"
FT   MOD_RES         104
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         132
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P62908"
FT   MOD_RES         209
FT                   /note="Phosphoserine; by IKKB"
FT                   /evidence="ECO:0000269|PubMed:21399639"
FT   MOD_RES         220
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         221
FT                   /note="Phosphothreonine; by CDK1 and PKC/PRKCD"
FT                   /evidence="ECO:0000269|PubMed:19059439,
FT                   ECO:0000269|PubMed:21871177, ECO:0000269|Ref.12,
FT                   ECO:0007744|PubMed:16964243, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16807684"
FT   MOD_RES         242
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:24275569"
FT   CROSSLNK        90
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT   CROSSLNK        214
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        214
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:28065601,
FT                   ECO:0000269|PubMed:28132843, ECO:0000269|PubMed:31981475,
FT                   ECO:0000269|PubMed:32011234, ECO:0000269|PubMed:34348161,
FT                   ECO:0000269|PubMed:34469731, ECO:0000269|PubMed:39609413,
FT                   ECO:0000269|PubMed:39947182"
FT   CROSSLNK        230
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         85
FT                   /note="E -> ELKIMVMVTGYPLLPLK (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_046667"
FT   MUTAGEN         6
FT                   /note="S->A: No effect on phosphorylation by CDK1. Greatly
FT                   reduced phosphorylation by PRKCD. Abolishes phosphorylation
FT                   by PRKCD; when associated with A-221."
FT                   /evidence="ECO:0000269|PubMed:19059439,
FT                   ECO:0000269|PubMed:21871177"
FT   MUTAGEN         18
FT                   /note="K->R: No effect on sumoylation. Abolishes
FT                   sumoylation; when associated with R-214 and R-230."
FT                   /evidence="ECO:0000269|PubMed:21968017"
FT   MUTAGEN         35
FT                   /note="S->A: No effect on phosphorylation by PRKCD."
FT                   /evidence="ECO:0000269|PubMed:19059439"
FT   MUTAGEN         42
FT                   /note="T->A: Abolishes phosphorylation by MAPK and
FT                   translocation to the nucleus following exposure of cells to
FT                   hydrogen peroxide. No effect on phosphorylation by CDK1 or
FT                   PRKCD."
FT                   /evidence="ECO:0000269|PubMed:15950189,
FT                   ECO:0000269|PubMed:17560175, ECO:0000269|PubMed:19059439,
FT                   ECO:0000269|PubMed:21871177"
FT   MUTAGEN         42
FT                   /note="T->D: Phosphomimetic mutant which is detected
FT                   exclusively in the nucleus."
FT                   /evidence="ECO:0000269|PubMed:17560175"
FT   MUTAGEN         70
FT                   /note="T->A: No effect on phosphorylation by PRKCD.
FT                   Abolishes phosphorylation by PKB."
FT                   /evidence="ECO:0000269|PubMed:19059439,
FT                   ECO:0000269|PubMed:20605787"
FT   MUTAGEN         70
FT                   /note="T->D,E,R: Abolishes phosphorylation by PKB."
FT                   /evidence="ECO:0000269|PubMed:20605787"
FT   MUTAGEN         132
FT                   /note="K->A: Does not affect ability to cleave DNA but
FT                   abolishes binding to 8-oxoG."
FT                   /evidence="ECO:0000269|PubMed:16737853"
FT   MUTAGEN         139
FT                   /note="S->A: No effect on phosphorylation by PRKCD."
FT                   /evidence="ECO:0000269|PubMed:19059439"
FT   MUTAGEN         149
FT                   /note="S->A: No effect on phosphorylation by PRKCD."
FT                   /evidence="ECO:0000269|PubMed:19059439"
FT   MUTAGEN         195
FT                   /note="T->A: No effect on phosphorylation by PRKCD."
FT                   /evidence="ECO:0000269|PubMed:19059439"
FT   MUTAGEN         209
FT                   /note="S->A: Reduced phosphorylation by IKKB."
FT                   /evidence="ECO:0000269|PubMed:21399639"
FT   MUTAGEN         214
FT                   /note="K->R: No effect on sumoylation. Abolishes
FT                   sumoylation; when associated with R-18 and R-230. Abolished
FT                   ubiquitination by RNF10 in response to ribosome stalling
FT                   and deubiquitination by USP10."
FT                   /evidence="ECO:0000269|PubMed:21968017,
FT                   ECO:0000269|PubMed:31981475, ECO:0000269|PubMed:34348161,
FT                   ECO:0000269|PubMed:39609413, ECO:0000269|PubMed:39947182"
FT   MUTAGEN         221
FT                   /note="T->A: No effect on phosphorylation by MAPK.
FT                   Significantly reduces phosphorylation by CDK1 and nuclear
FT                   accumulation. Greatly reduced phosphorylation by PRKCD.
FT                   Abolishes phosphorylation by PRKCD; when associated with
FT                   A-6."
FT                   /evidence="ECO:0000269|PubMed:15950189,
FT                   ECO:0000269|PubMed:19059439, ECO:0000269|PubMed:21871177"
FT   MUTAGEN         227
FT                   /note="K->R: Does not affect ubiquitination in response to
FT                   ribosome stalling."
FT                   /evidence="ECO:0000269|PubMed:31981475,
FT                   ECO:0000269|PubMed:34348161"
FT   MUTAGEN         230
FT                   /note="K->R: No effect on sumoylation. Abolishes
FT                   sumoylation; when associated with R-18 and R-214. Does not
FT                   affect ubiquitination in response to ribosome stalling."
FT                   /evidence="ECO:0000269|PubMed:21968017,
FT                   ECO:0000269|PubMed:31981475, ECO:0000269|PubMed:34348161"
FT   CONFLICT        8
FT                   /note="K -> R (in Ref. 2; AAB19349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        104
FT                   /note="S -> C (in Ref. 1; CAA39248)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        233
FT                   /note="P -> L (in Ref. 1; CAA39248)"
FT                   /evidence="ECO:0000305"
FT   HELIX           7..29
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           30..32
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          34..41
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          46..53
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           55..59
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           61..63
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           64..77
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          83..89
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           94..96
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           98..109
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   TURN            110..112
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   HELIX           115..128
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          132..140
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          142..146
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          148..155
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:6ZXG"
FT   HELIX           163..167
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          168..177
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          180..189
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          194..199
FT                   /evidence="ECO:0007829|PDB:7R4X"
FT   STRAND          223..226
FT                   /evidence="ECO:0007829|PDB:6ZLW"
SQ   SEQUENCE   243 AA;  26688 MW;  6ECBB34A8EE04AAF CRC64;
     MAVQISKKRK FVADGIFKAE LNEFLTRELA EDGYSGVEVR VTPTRTEIII LATRTQNVLG
     EKGRRIRELT AVVQKRFGFP EGSVELYAEK VATRGLCAIA QAESLRYKLL GGLAVRRACY
     GVLRFIMESG AKGCEVVVSG KLRGQRAKSM KFVDGLMIHS GDPVNYYVDT AVRHVLLRQG
     VLGIKVKIML PWDPTGKIGP KKPLPDHVSI VEPKDEILPT TPISEQKGGK PEPPAMPQPV
     PTA
//
